CATALYST PHARMACEUTICALS, INC. Underwriting Agreements
9 Contracts & Agreements
- Underwriting Agreement dated January 4, 2024, between Catalyst Pharmaceuticals, Inc. and BofA Securities, Inc. and Citigroup Global Markets, Inc., as representatives of the... (Filed With SEC on January 5, 2024)
- Underwriting Agreement, dated November 28, 2017, between Catalyst Pharmaceuticals, Inc. and Piper Jaffray & Co., as representative of the underwriters named in Schedule I thereto (Filed With SEC on November 28, 2017)
- 13,023,750 Shares CatalystPharmaceutical Partners, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on April 3, 2014)
- 6,000,000 Shares Warrants to Purchase 6,000,000 Shares Catalyst Pharmaceutical Partners, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on May 29, 2012)
- [ ] Shares Warrants to Purchase [ ] Shares Catalyst Pharmaceutical Partners, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on May 4, 2012)
- [ ] Shares Catalyst Pharmaceutical Partners, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on April 25, 2012)
- CATALYST PHARMACEUTICAL PARTNERS, INC. 3,046,740 shares of Common Stock and Warrants to purchase up to 1,523,370 shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on October 28, 2011)
- 2,259,943 Shares CATALYST PHARMACEUTICAL PARTNERS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on March 8, 2011)
- EX-1.1 Form of Underwriting Agreement (Filed With SEC on September 26, 2006)
